Hepatitis C virus infection in the human immunodeficiency virus infected patient, World Journal of Gastroenterology, vol.20, issue.34, pp.12132-12175, 2014. ,
DOI : 10.3748/wjg.v20.i34.12132
HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies, Current HIV/AIDS Reports, vol.49, issue.3, pp.12-22, 2011. ,
DOI : 10.1007/s11904-010-0071-3
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence, Hepatology, vol.29, issue.Suppl ,
DOI : 10.1002/hep.26141
Epidemiology of hepatitis C virus in HIV-infected patients, Current Opinion in HIV and AIDS, vol.10, issue.5, pp.297-302, 2015. ,
DOI : 10.1097/COH.0000000000000183
Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.15, issue.7, pp.819-824, 2015. ,
DOI : 10.1016/S1473-3099(15)00006-7
Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa, Journal of Clinical Virology, vol.61, issue.1, pp.20-33, 2014. ,
DOI : 10.1016/j.jcv.2014.05.018
Prise en charge des personnes infectées par les virus de l'Hépatite B ou de l'Hépatite C ,
Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France, Liver International, vol.4, issue.27, pp.65-70, 2015. ,
DOI : 10.1111/liv.12639
invs.sante.fr/Dossiers-thematiques/Maladies- infectieuses/VIH-sida-IST/Donneurs-de-sang/La-surveillance-epidemiologique-des- donneurs-de-sang-VIH-VHC-VHB-HTLV-syphilis ,
HIV and hepatitic C virus co-infection Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a « special population, Lancet Infect Dis. World J Hepatol, vol.47, issue.13, pp.437-441936, 2004. ,
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study, Hepatology, vol.32, issue.5 Suppl. 1, pp.881-889, 2013. ,
DOI : 10.1002/hep.26164
Sexual Transmission of HCV between Spouses, The American Journal of Gastroenterology, vol.2, issue.4, pp.821-824, 2005. ,
DOI : 10.1111/j.1572-0241.2004.04150.x
Lack of Evidence of Sexual Transmission of Hepatitis C among Monogamous Couples: Results of a 10-Year Prospective Follow-Up Study, The American Journal of Gastroenterology, vol.20, issue.1, pp.855-859, 2004. ,
DOI : 10.1046/j.1440-1746.2000.02165.x
Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Sex Transm Infect Clinical présentation and course of acute hepatitis C infection in HIV-infected patients, The Hepatitis C epidemic among HIV-positive MSM: incidence estimates from, pp.326-333, 1990. ,
Infection par le VIH et grossesse??: nouvelles recommandations 2013??du groupe d???experts fran??ais, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.43, issue.7, pp.534-582, 2014. ,
DOI : 10.1016/j.jgyn.2014.01.006
Hepatitis C virus in pregnancy, Am J Perinatol, vol.30, pp.149-159, 2013. ,
Impact of Maternal HIV Coinfection on the Vertical Transmission of Hepatitis C Virus: A Meta-analysis, Clinical Infectious Diseases, vol.44, issue.8, pp.1123-1131, 2007. ,
DOI : 10.1086/512815
Anamnesis and diagnosis of hepatitis C, J Pharm Clin, vol.25, pp.49-56, 2006. ,
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection, Hepatol. J Hepatol, vol.3455, issue.28, pp.730-9245, 2001. ,
Natural history of hepatitis C, Journal of Hepatology, vol.61, issue.1, pp.58-68, 2014. ,
DOI : 10.1016/j.jhep.2014.07.012
Estimating progression to cirrhosis in chronic hepatitis C virus infection, Hepatology, vol.34, issue.4, pp.809-825, 2001. ,
DOI : 10.1053/jhep.2001.27831
Prise en charge des personnes infectées par les virus de l'Hépatite B ou de l'Hépatite C ,
HCV-associated liver cancer without cirrhosis, The Lancet, vol.345, issue.8947, pp.413-418, 1995. ,
DOI : 10.1016/S0140-6736(95)90400-X
HCV and HIV co-infection: mechanisms and management, Nature Reviews Gastroenterology & Hepatology, vol.18, issue.6, pp.362-371, 2014. ,
DOI : 10.1038/nrgastro.2014.17
Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection, European Journal of Immunology, vol.77, issue.12, pp.3493-3504, 2005. ,
DOI : 10.1002/eji.200535035
Pathogenesis of Accelerated Fibrosis in HIV/HCV Co-infection, Journal of Infectious Diseases, vol.207, issue.suppl 1, pp.13-18, 2013. ,
DOI : 10.1093/infdis/jis926
The Natural History of Hepatitis C Virus Infection, JAMA, vol.284, issue.4 ,
DOI : 10.1001/jama.284.4.450
AN effective interféron-gamma-mediated inhibition of hepatitis C virus réplication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease, Hepatology. Blood, vol.5984, pp.814-8271020, 1994. ,
Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia, Journal of Viral Hepatitis, vol.47, issue.7, pp.161-169, 2011. ,
DOI : 10.1111/j.1365-2893.2010.01289.x
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a metaanalysis, Hepatology. Clin Infect Dis, vol.3033, pp.1054-1062, 1999. ,
HIV coïnfection shortens the survival of patients with hepatitis C virusrelated decompensated cirrhosis, Hepatology, vol.41, pp.779-89, 2005. ,
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.???Canadian multicenter study, Journal of Hepatology, vol.47, issue.4 ,
DOI : 10.1016/j.jhep.2007.06.010
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antirétroviral therapy, J Hepatol, vol.44, pp.47-55, 2006. ,
Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy, Hepatology, vol.46, pp.622-652, 2007. ,
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis, AIDS, vol.22, issue.15, pp.1979-91, 2008. ,
DOI : 10.1097/QAD.0b013e32830e6d51
The Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey, HIV Med, vol.16, pp.230-239, 1995. ,
Natural history of liver disease and effect of hepatitis C virus on HIV disease progression, Current Opinion in HIV and AIDS, vol.10, issue.5, pp.303-308, 2015. ,
DOI : 10.1097/COH.0000000000000187
Influence of Hepatitis C Virus Infection on HIV???1 Disease Progression and Response to Highly Active Antiretroviral Therapy, The Journal of Infectious Diseases, vol.192, issue.6, pp.992-1002, 2005. ,
DOI : 10.1086/432762
Hepatitis C virus/HIV coïnfection and responses to initial antiretroviral treatment Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus Diagnostic discordance for hepatitis C virus infection in hemodialysis patients, AIDS. J Infect Dis. Am J Kidney Dis, vol.2720146, issue.57, pp.2725-2734823, 2005. ,
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals, J Clin Microbiol, vol.38, pp.575-582, 2000. ,
Hepatitis C virus (HCV) viremia in HIV-infected patients without HCV antibodies détectable by thirdgeneration enzyme immunoassay, J Gastroenterol Hepatol, vol.9, pp.1506-1515, 2007. ,
Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype, Alimentary Pharmacology & Therapeutics, vol.19, issue.11-12, pp.1489-98, 2007. ,
DOI : 10.1111/j.1365-2036.2007.03533.x
URL : https://hal.archives-ouvertes.fr/inserm-00177055
Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs, Hepatology, vol.1, issue.3, pp.767-75, 2014. ,
DOI : 10.1002/hep.26741
Association of Noncirrhotic Portal Hypertension in HIV???Infected Persons and Antiretroviral Therapy with Didanosine: A Nested Case???Control Study, Clinical Infectious Diseases, vol.49, issue.4, pp.626-661, 2009. ,
DOI : 10.1086/603559
Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration, HIV Medicine, vol.50, issue.1 Pt 1, pp.30-39, 2014. ,
DOI : 10.1111/hiv.12082
Diagnosis of Hepatic Fibrosis and Cirrhosis by Transient Elastography in HIV/Hepatitis C Virus-Coinfected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.2, pp.175-184, 2006. ,
DOI : 10.1097/01.qai.0000194238.15831.c7
Prise en charge médicale des personnes infectées par le VIH. Medecine- Sciences Flammarion ed, 2008. ,
Peginterferon-alpha-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients, N Engl J Med, vol.351, pp.438-450, 2004. ,
Differences in virological response to pegylated interferon and ribavirine between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients, Antivir Ther, vol.13, pp.1047-55, 2008. ,
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial, The Lancet Infectious Diseases, vol.13, issue.7, pp.597-605, 2013. ,
DOI : 10.1016/S1473-3099(13)70149-X
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.364, issue.25, pp.2405-2421, 2011. ,
DOI : 10.1056/NEJMoa1012912
Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial, Clinical Infectious Diseases, vol.59, issue.12, p.trial ,
DOI : 10.1093/cid/ciu659
URL : https://hal.archives-ouvertes.fr/hal-01118447
Bocepreprevir for previously treated HCV-HIV coinfected patients: The ANRS-HC27 BocepreVIH Trial Triple therapy with boceprevir or telaprevir in European cohort of cirrhotic HIV/HCV génotype 1-coinfected patients, Conference on Retroviruses and Opportunistic Infections Liver Int, vol.35, pp.2090-2099, 2014. ,
Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients, European Journal of Gastroenterology & Hepatology, vol.27, issue.2, pp.123-132, 2015. ,
DOI : 10.1097/MEG.0000000000000241
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver Use of first-generation HCV protéase inhibitors in patients coinfected by HIV and HCV genotype 1, Liver Int. Liver Int, vol.3234, issue.84, pp.1477-92869, 2012. ,
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection, Nature Reviews Microbiology, vol.90, issue.7, pp.482-96, 2013. ,
DOI : 10.1038/nrmicro3046
URL : https://hal.archives-ouvertes.fr/hal-00972320
Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study, Clinical Infectious Diseases, vol.59, issue.11, pp.1579-87, 2014. ,
DOI : 10.1093/cid/ciu675
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study, The Lancet, vol.385, issue.9973, pp.1098-106, 2015. ,
DOI : 10.1016/S0140-6736(14)62483-1
Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection, JAMA, vol.313, issue.12, pp.1232-1241, 2015. ,
DOI : 10.1001/jama.2015.1373
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial, The Lancet, vol.385, issue.9973, pp.1087-97, 2015. ,
DOI : 10.1016/S0140-6736(14)61793-1
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1, New England Journal of Medicine, vol.373, issue.8, pp.705-718, 2015. ,
DOI : 10.1056/NEJMoa1501315
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1, JAMA, vol.313, issue.12, pp.1223-1254, 2015. ,
DOI : 10.1001/jama.2015.1328
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial, The Lancet HIV, vol.2, issue.8, pp.319-346, 2015. ,
DOI : 10.1016/S2352-3018(15)00114-9
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?, Clinical Infectious Diseases, vol.62, issue.7, pp.919-945, 2016. ,
DOI : 10.1093/cid/civ1222
Daclatasvir plus Sofosbuvir with or without ribavirin in patients with HIV-HCV coinfection: intérim analysis of a French multicenter compassoinate use program. 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2015. ,
Directly acting agents against HCV -Results from the GErman hepatitis C COhort (GECCO), 2016. ,
P0775 : Final evaluation of 955 HCV patients treated with 12 week regimens containing sofosbuvir +/- simeprevir in the trio network: Academic and community treatment of a real-world, heterogeneous population, Journal of Hepatology, vol.62, p.621, 2015. ,
DOI : 10.1016/S0168-8278(15)30978-8
LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*, Journal of Hepatology, vol.62, p.258, 2015. ,
DOI : 10.1016/S0168-8278(15)30149-5
URL : https://hal.archives-ouvertes.fr/hal-01162711
Key drug???drug interactions with direct-acting antiviral in HIV???HCV coinfection, Current Opinion in HIV and AIDS, vol.10, issue.5, pp.348-54, 2015. ,
DOI : 10.1097/COH.0000000000000185
Sofosbuvir: A novel treatment option for chronic hepatitis C infection, J Pharmacol Pharmacother, vol.5, pp.278-84, 2014. ,
Key drug???drug interactions with direct-acting antiviral in HIV???HCV coinfection, Current Opinion in HIV and AIDS, vol.10, issue.5, pp.348-354, 2015. ,
DOI : 10.1097/COH.0000000000000185
Synthèse des interactions entre traitements antiretroviral et anti-VHC. Actualisation décembre 2015, 2016. ,
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir., Antiviral Therapy, vol.18, issue.7, pp.931-940, 2013. ,
DOI : 10.3851/IMP2674
Drug interactions between the anti-HCV regimen Ledipasvir ,
Exviera and Viekirax Combination Treatment in co-infected HIV- HCV patients: preliminary results of a Compassionate Use program. Italian Society for Tropical Medecine and Infectious Diseases, pp.9-11, 2015. ,